[1] Forkin KT, Colquhoun DA, Nemergut EC, et al. The coagulation profile of end-stage liver disease and considerations for intraoperative management. Anesth Analg, 2018, 126:46-61.
[2] Lisman T, Stravitz RT. Rebalanced hemostasis in patients with acute liver failure. Semin Thromb Hemost, 2015, 41: 468-473.
[3] Hoffman M. Coagulation in liver disease. Semin Thromb Hemost, 2015, 41: 447-454.
[4] Ambrosino P, Tarantino L, Di Minno G, et al. The risk of venous thromboembolism in patients with cirrhosis. A systematic review and meta-analysis. Thromb Haemost, 2017, 117:139-148.
[5] Qi X, Ren W, Guo X, et al. Epidemiology of venous thromboembolism in patients with liver diseases: a systematic review and meta-analysis. Intern Emerg Med, 2015, 10:205-217.
[6] Zhang X, Qi X, De Stefano V, et al. Epidemiology, risk factors, and in-hospital mortality of venous thromboembolism in liver cirrhosis: a single-center retrospective observational study. Med Sci Monit, 2016, 22:969-976.
[7] Ali M, Ananthakrishnan AN, McGinley EL, et al. Deep vein thrombosis and pulmonary embolism in hospitalized patients with cirrhosis: a nationwide analysis. Dig Dis Sci, 2011, 56:2152-2159.
[8] Sarin SK, Choudhury A, Sharma MK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int, 2019, 13:353-390.
[9] O'Leary JG, Greenberg CS, Patton HM, et al. AGA Clinical Practice Update: Coagulation in Cirrhosis. Gastroenterology, 2019, 157:34-43.e1.
[10] Saner FH, Bezinover D. Assessment and management of coagulopathy in critically-ill patients with liver failure. Curr Opin Crit Care, 2019, 25:179-186.
[11] 江晓燕, 甘巧蓉, 李孝楼, 等. 血栓弹力图评价乙型肝炎病毒相关慢加急性肝衰竭患者出血风险及预后价值研究. 传染病信息, 2019, 32:54-57.
[12] 曾艳丽, 高飞, 魏君峰, 等. 血栓弹力图评价慢加急性肝衰竭患者的凝血功能及预后研究. 中华肝脏病杂志, 2017, 25:32-37.
[13] European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, Clinical practice guidelines panel, Wendon J, et al. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol, 2017, 66:1047-1081.
[14] Henke PK, Kahn SR, Pannucci CJ, et al. Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart Association. Circulation, 2020, 141:e914-e931.
[15] Intagliata NM, Davis J, Caldwell SH. Coagulation Pathways, Hemostasis, and thrombosis in liver failure. Semin Respir Crit Care Med, 2018, 39:598-608.
[16] Nanchal R, Subramanian R, Karvellas CJ, et al. Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Cardiovascular, Endocrine, Hematologic, Pulmonary, and Renal Considerations. Crit Care Med, 2020, 48:e173-173e191.
[17] 中华医学会外科学分会血管外科学组. 深静脉血栓形成的诊断和治疗指南(第三版). 中华普通外科杂志, 2017, 32:807-812.
[18] 中华医学会呼吸病学分会肺栓塞与肺血管病学组, 中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会, 全国肺栓塞与肺血管病防治协作组. 肺血栓栓塞症诊治与预防指南. 中华医学杂志, 2018, 98:1060-1087.
[19] 《中国血栓性疾病防治指南》专家委员会. 中国血栓性疾病防治指南. 中华医学杂志, 2018, 98:2861-2888.
[20] Allison MG, Shanholtz CB, Sachdeva A. Hematological issues in liver disease. Crit Care Clin, 2016, 32:385-396. |
